Active Half-life (Days): 7 days
Group: Anabolic Steroids
Subgroup: Injection
Dosage: 75 mg/ml
Application (Men): 150-600 mg a week
Product pack: 10ml vial
Content (active): Trenbolone Hexahydrobenzylcarbonate
Oil-based: Yes
Retains water: No
Aromatication No
In the late 1960s, French Negma Labs produced Parabolan, the first and only Trenbolone hormone for human use. For years, it was used to treat malnutrition, osteoporosis and cachexia before being discontinued in 1997. Trenbolone is far more anabolic and androgenic than Testosterone. This is a hallmark trait of the Parabolan: with it, users can expect massive gains in lean muscle mass; strength increases; elevation of oxygen levels in red blood cells to encourage greater output from aerobic cellular respiration (muscle tissue regeneration); increased insulin-like growth factor-1 (IFR-1) production; and faster fat loss. The most common side effects associated with Parabolan include acne, temporary testosterone suppression, high LDL cholesterol levels, mood swings, insomnia and aggression.